---
DrugClass: "[[Antibacterial(Drugs That Interfere With Protein Synthesis)]]"
DrugClassContra: "[[Lincosamides#Contraindications]]"
DrugClassAdverse: "[[Lincosamides#Adverse Reactions]]"
SubClass: "[[Lincosamides]]"
SecondaryDrugClass: 
SecondarySubClass: 
BrandName: Lincocin
Chapter: "8"
KindleLinkChap: "[Chapter 8](kindle://book?action=open&asin=B09FRF11YJ&location=4155)"
KindleLink: 
tags:
  - Drug
  - Pharmacology
Course: Pharmacology
---
```smiles
CCC[C@@H]1C[C@H](N(C1)C)C(=O)N[C@@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)[C@@H](C)O
```

### Brand name
`=this.BrandName`
### Generic name
`= this.file.name`

### Drug class 
`= this.DrugClass`
	`= this.DrugClass.KindleLinkChap`

### Dosage & Usage
Serious bacterial infections 
500 mg orally every 6– 8 hr; 600 mg IM every 12– 24 hr; up to 8 g/ day IV in life-threatening situations

### Contraindications
See `= this.DrugClassContra`

### Mechanisms of Action

### Side/Adverse Effects
See `= this.DrugClassAdverse`
Same as [[clindamycin#Side/Adverse Effects]]
### Interactions
